Cargando…

EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma

BACKGROUND: Glioma is the most prevalent primary tumor of the central nervous system. Glioblastoma multiforme (GBM) is the most malignant form of glioma with an extremely poor prognosis. A novel, regulated cell death form of copper-induced cell death called “cuproptosis” provides a new prospect for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yujie, Xiao, Dongdong, Jiang, Xiaobing, Nie, Chuansheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843967/ https://www.ncbi.nlm.nih.gov/pubmed/36647156 http://dx.doi.org/10.1186/s12967-023-03883-4

Ejemplares similares

CD155, an onco‐immunologic molecule in human tumors
por: Gao, Jian, et al.
Publicado: (2017)

A Ferroptosis-Related Prognostic Risk Score Model to Predict Clinical Significance and Immunogenic Characteristics in Glioblastoma Multiforme
por: Xiao, Dongdong, et al.
Publicado: (2021)

LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification
por: Zhou, Yujie, et al.
Publicado: (2022)

Polymorphism in the EREG gene confers susceptibility to tuberculosis
por: Cao, Wen, et al.
Publicado: (2019)

The Role of EREG/EGFR Pathway in Tumor Progression
por: Cheng, Wan-Li, et al.
Publicado: (2021)

RPP25 as a Prognostic-Related Biomarker That Correlates With Tumor Metabolism in Glioblastoma
por: Xiao, Dongdong, et al.
Publicado: (2022)

BMP7 and EREG Contribute to the Inductive Potential of Dental Mesenchyme
por: Gao, Bo, et al.
Publicado: (2015)

EREG is a risk factor for the prognosis of patients with cervical cancer
por: Li, Tianye, et al.
Publicado: (2023)

The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology
por: Hugonnet, Marjolaine, et al.
Publicado: (2021)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma
por: Chu, Binxiang, et al.
Publicado: (2022)

Cancer cell immune mimicry delineates onco-immunologic modulation
por: Gao, Rui, et al.
Publicado: (2021)

Syringic acid mitigates isoproterenol‐induced cardiac hypertrophy and fibrosis by downregulating Ereg
por: Han, Xiongyi, et al.
Publicado: (2022)

Systematic analysis of cuproptosis-related genes in immunological characterization and predictive drugs in Alzheimer’s disease
por: Nie, Bin, et al.
Publicado: (2023)

Novel TGF-β inhibitors ready for prime time in onco-immunology
por: de Gramont, Armand, et al.
Publicado: (2016)

Construction and validation of a cuproptosis-related prognostic model for glioblastoma
por: Zhang, Bohong, et al.
Publicado: (2023)

The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
por: Curcio, Claudia, et al.
Publicado: (2021)

CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and Invasion
por: Cardoso, Lais C., et al.
Publicado: (2019)

Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease
por: Lai, Yongxing, et al.
Publicado: (2022)

Identification and immunological characterization of cuproptosis-related molecular clusters in ulcerative colitis
por: Pu, Yunfei, et al.
Publicado: (2023)

Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer
por: Lee, Michael S, et al.
Publicado: (2016)

RHOA GTPase Controls YAP-Mediated EREG Signaling in Small Intestinal Stem Cell Maintenance
por: Liu, Ming, et al.
Publicado: (2017)

Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction
por: Jehl, Aude, et al.
Publicado: (2023)

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
por: Xiao, Chen, et al.
Publicado: (2022)

Correction to: Identification and immunological characterization of cuproptosis-related molecular clusters in ulcerative colitis
por: Pu, Yunfei, et al.
Publicado: (2023)

A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
por: Li, He, et al.
Publicado: (2022)

Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
por: Qu, X, et al.
Publicado: (2016)

EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy
por: Liu, Shuli, et al.
Publicado: (2020)

The role of TGR5 as an onco-immunological biomarker in tumor staging and prognosis by encompassing the tumor microenvironment
por: Guan, Zhiyuan, et al.
Publicado: (2022)

Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

Identification and immunological characterization of cuproptosis-related molecular clusters in idiopathic pulmonary fibrosis disease
por: Shi, Xuefeng, et al.
Publicado: (2023)

Analysis of cuproptosis-related genes in Ulcerative colitis and immunological characterization based on machine learning
por: Wang, Zhengyan, et al.
Publicado: (2023)

PyOncoPrint: a python package for plotting OncoPrints
por: Park, Jeongbin, et al.
Publicado: (2023)

Introducing, OncoTarget
Publicado: (2010)

Onco-urology Abstracts
Publicado: (2015)

Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma
por: Shen, Yefeng, et al.
Publicado: (2023)

OncoSim and OncoWiki: an authentic learning approach to teaching cancer genomics
por: Schoenborn, Priska, et al.
Publicado: (2019)

Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma
por: Burgy, Mickaël, et al.
Publicado: (2021)

Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma
por: Li, Mengwei, et al.
Publicado: (2022)

NONHSAT021545/miR-330-3p/EREG: A Cooperative Axis in Breast Cancer Prognosis and Treatment
por: Zhang, Yunkun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o99uegvqn6j2stbrt7km98kg2k